Kim Cocks

9.3k citations
120 papers · 7.3k · 4 hit papers · h-index 38

Impact in

  • Hematology top 0.5%
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Oncology top 1%
    • Cancer survivorship and care
    • Bone health and treatments
    • Cancer Immunotherapy and Biomarkers

Papers in

Kim Cocks

117 papers receiving 7.1k citations

Kim Cocks's Hit Papers

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial 2017 · 349 citations
3490+7+15Years since publication5001k1.5k

Peers

Kim Cocks
Comparison fields: 5 of 144
  • Hematology 2.4k
  • Oncology 2.2k
  • Otorhinolaryngology 284
  • Statistics and Probability 358
  • Occupational Therapy 169
Replace Andrea Bezjak with:
Andrea Bezjak Canada
Navneet S. Majhail United States
Eleanor T. Mcfadden United States
Joseph L. Pater Canada
Chris Leo Pashos United States
Fabio Efficace Italy
Andrew Bottomley Belgium
S Schraub France
Richard H. Creech United States
Kommer C.A. Sneeuw Netherlands
Kim Cocks relative to Andrea Bezjak Canada Andrea Bezjak's profile →
Citations per field
00.5×2×4×6×8×9.5×
Andrea Bezjak · 1×
Citations per year

Countries citing papers authored by Kim Cocks

Since Specialization
Citations

This map shows the geographic impact of Kim Cocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Cocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Cocks more than expected).

Fields of papers citing papers by Kim Cocks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Cocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Cocks. The network helps show where Kim Cocks may publish in the future.

Co-authors

The 25 scholars most cited alongside Kim Cocks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kim Cocks Line = papers co-authored together Kim Cocks links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.

#Work
1
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
Hit paper breakdown →
20031509
2
Evidence-Based Guidelines for Determination of Sample Size and Interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30
Hit paper breakdown →
2010565
3 2010461
4
Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30
Hit paper breakdown →
2012428
5
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial
Hit paper breakdown →
2017349
6 2012329
7 2020252
8 2007201
9 2016165
10 2008152
11 2010148
12 2011134
13 2006117
14 2022105
15 2017103
16 2023102
17 201880
18 200579
19 201976
20 201371

About Kim Cocks

Kim Cocks is a scholar working on Oncology, Economics and Econometrics, Hematology, Statistics and Probability and Genetics, having authored 120 papers that have together received 7.3k indexed citations. Recurring topics across this work include Cancer survivorship and care (48 papers), Health Systems, Economic Evaluations, Quality of Life (40 papers), Multiple Myeloma Research and Treatments (16 papers), Statistical Methods in Clinical Trials (13 papers), Chronic Lymphocytic Leukemia Research (6 papers), Psychometric Methodologies and Testing (6 papers), Patient Safety and Medication Errors (5 papers) and Patient Satisfaction in Healthcare (3 papers). The work is most often cited by research in Hematology (2.4k citations), Oncology (2.2k citations), Otorhinolaryngology (284 citations), Statistics and Probability (358 citations) and Occupational Therapy (169 citations). Kim Cocks has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Julia M. Brown, Galina Velikova, Madeleine Trudy King, Gareth John Morgan, Faith E. Davies, Mark Trehane Drayson, Roger G. Owen, David John Torgerson, Peter John Selby and Peter M. Fayers. Their work appears in journals such as Value in Health, Quality of Life Research, Blood, The Lancet Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact